Paper Review Records
全部论文审稿周期
9 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
155
天
Adjunctive Varespladib after antivenom administration for snakebite: A phase II randomized clinical trial
作者
Charles J. Gerardo; Ashish Bhalla; Chitta R. Mohanty; Badal K. Sahu; Surendra Kumar; Suneil Agrawal; Manu Ayyan S; Eileen Shu; Travis Deuson; Madhu Kumar R; Norman L. Beatty; Peter D. Akpunonu; Farshad M. Shirazi; Sarah Watkins; Anne-Michelle Ruha; Shawn M. Varney; Anil K. Goel; Medhavi Gautam; Justin Arnold; Chanaveerappa Bammigatti; Samuel J. Francis; Suresh Selvam; Harish Kumar; Adiel Aizenberg; Andrew Micciche; Rylee S. Bledsoe; Ginger Boatright; Suraj C. Oomman; Stephen P. Samuel; Janet T. Wittes; Rebecca W. Carter; Matthew R. Lewin; Timothy F. Platts-Mills展开收起
作者单位
1. Duke University Hospital, Durham, North Carolina, United States of America; 2. Postgraduate Institute of Medical Education and Research, Chandigarh, India; 3. All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India; 4. Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, India; 5. Sardar Patel Medical College, Bikaner, Rajasthan, India; 6. Desert Regional Medical Center, Palm Springs, California, United States of America; 7. Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India; 8. Antelope Valley Medical Center, Lancaster, California, United States of America; 9. KR Hospital, Mysore Medical College and Research Institute, Mysore, Karnataka, India; 10. University of Florida College of Medicine, Gainesville, Florida, United States of America; 11. College of Medicine, University of Kentucky, Lexington, Kentucky, United States of America; 12. Arizona Poison and Drug Information Center, University of Arizona, Tucson, Arizona, United States of America; 13. Texas Tech University Health Sciences, El Paso, Texas, United States of America; 14. Banner University Medical Center, Phoenix, Arizona, United States of America; 15. University of Texas Health-San Antonio, San Antonio, Texas, United States of America; 16. All India Institute of Medical Sciences, Raipur, Chhattisgarh, India; 17. King George University Hospital, Lucknow, Uttar Pradesh, India; 18. Tampa General Hospital, Tampa, Florida, United States of America; 19. Ophirex, Inc., Corte Madera, California, United States of America; 20. Wittes, LLC, Washington, United States of America; 21. California Academy of Sciences, San Francisco, California, United States of America展开收起
162
天
Individual-level agreement between coverage surveys and treatment registers in mass drug administration: A secondary analysis of the multi-country DeWorm3 cluster randomized trial
作者
Elohor Oborevwori; Kristjana Ásbjörnsdóttir; Sean Galagan; Katherine Sharrock; Kumudha Aruldas; Saravanakumar Puthupalayam Kaliapan; Rachael Pullan; Robin Bailey; Khumbo Kalua; James Simwanza; Stefan Witek-McManus; Moudachirou Ibikounlé; Adrian J. F. Luty; Sitara Swarna Rao Ajjampur; Arianna Means; Judd L. Walson展开收起
作者单位
1. Department of Research, Johns Hopkins University School of Nursing, Baltimore, Maryland, United States of America; 2. Centre of Public Health Sciences, University of Iceland, Reykjavík, Iceland; 3. Department of Global Health, University of Washington, Seattle, Washington, United States of America; 4. The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India; 5. Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; 6. Blantyre Institute for Community Outreach, Lions Sight First Eye Hospital, Blantyre, Malawi; 7. Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; 8. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; 9. Institut de Recherche Clinique du Benin, Abomey-Calavi, Benin; 10. Centre de Recherche pour la lutte contre les Maladies Infectieuses Tropicales, Université d’Abomey-Calavi, Abomey-Calavi, Benin; 11. Université Paris Cité, Institute of Research for Development, (IRD), National Institute of Health and Medical Research (INSERM), International Health of Mother and Child (MERIT), Paris, France; 12. Departments of International Health, Medicine and Pediatrics, Johns Hopkins University, Baltimore, Maryland, United States of America展开收起
328
天
Plasmodium knowlesi tryptophan-rich antigen 40.1 binds human erythrocyte spectrin alpha
作者
Wang-Jong Lee; Fadhila Fitriana; Jadidan Hada Syahada; Johnsy Mary Louis; Hyun-Young Sim; Ernest Mazigo; Hojong Jun; Fauzi Muh; Feng Lu; Seok Ho Cha; Se Jin Lee; Sunghun Na; Wanjoo Chun; Won Sun Park; Yee Ling Lau; Robert W. Moon; Eun-Taek Han; Jin-Hee Han展开收起
作者单位
1. Department of Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea; 2. Department of Epidemiology and Tropical Diseases, Faculty of Public Health, Universitas Diponegoro, Semarang, Indonesia; 3. Department of Parasitic Diseases and Vector Control, National Institute for Medical Research, Dar es Salaam, Tanzania; 4. Department of Pathogen Biology and Immunology, School of Medicine, Yangzhou University, Yangzhou, China; 5. Department of Parasitology and Tropical Medicine, Inha University School of Medicine, Incheon, Republic of Korea; 6. Department of Obstetrics and Gynecology, Kangwon National University Hospital, Chuncheon, Republic of Korea; 7. Department of Pharmacology, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea; 8. Department of Physiology, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea; 9. Department of Parasitology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; 10. Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; 11. Institute of Medical Sciences, Kangwon National University, Chuncheon, Republic of Korea展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天